Training our immune systems: Why we should insist on a high-quality COVID-19 vaccine
Roche working “around the clock” to tackle UK test supply problems
GSK and Vir expand COVID-19 antibody trial after Trump’s treatment with Regeneron’s rival
Every COVID-19 case seems different; these scientists want to know why
If COVID-19 Antibody 'Cocktails' Become Popular, Sorrento Stock Could Double, Says Analyst
EU Close – Stocks rise on COVID Treatment news and slow stimulus talks, Little reaction to Powell, Oil’s trifecta, Gold softens
How the leading coronavirus vaccines work
Dried blood spot sampling offers inexpensive way to widen access to antibody testing for COVID-19
GSK, Vir cleared to leap into PhIII, angling for a spot in the Covid-19 antibody race led by Lilly, Regeneron
Race for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jab
Sigh, yes, the ‘COVID virus’ is real
The 6 Degrees of Separating Coronavirus from President Trump
News briefing: Kronos Bio sets terms for IPO, flirting with billion-dollar unicorn valuation; Corvus collabs with spinout, unveils positive Covid-19 data
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
Regeneron: Initial Data From REGN-COV2 Trial Shows Promise, but Capacity Remains an Issue
Trump Urges Stimulus Deal Via Tweet As MSM Reports His Condition "Far More Dire" Than White House Says
Trump treated with experimental antibody cocktail for Covid-19
Cascend: COVID Mortality Of A 74-Year-Old Man Is 2.68%
Older people like President Trump are at more risk from COVID-19 because of how the immune system ages
Gene Therapy’s Renaissance
Spatial: The Next Omics Frontier
European regulators begin rolling review of AZ’s COVID-19 vaccine
The Unscientific Attack On The Science Of Dr. Scott Atlas
Caltech researcher unveils sensor that rapidly detects COVID-19 infection
Moderna says Covid-19 vaccine unlikely to be ready before U.S. election – FT
AstraZeneca’s Covid-19 Vaccine Put On Fast Track By EU Regulator
Researchers advance COVID-19 antibody knowledge with paper in journal
One small part of a human antibody has the potential to work as a drug for both prevention and therapy of COVID-19
MRNA Stock Price Pushes Higher On News COVID-19 Vaccine Works For Seniors
Goldman Sachs Predicts Over 40% Rally for These 3 Stocks